Purchase Order 75D30123P18122
Award Date
9/29/23
Potential Completion Date
9/28/24
Potential Value
$60K
Federal Agency
CDC Pittsburgh
Awardee
Qiagen, LLC
Ultimate Awardee
Qiagen N.V.
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed price purchase order contract to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $38,760.96 contract is for laboratory supplies to be delivered by November 1, 2022. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs under past...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to Qiagen, LLC, a division of Qiagen N.V., for the acquisition of QIAGEN equipment and reagents. The contract, valued at $134,538.38, does not have a set-aside designation. Qiagen N.V. is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academic research. The company has a history of supporting federal...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $57,348.26 firm fixed-price purchase order contract to Qiagen, LLC, a division of the international provider Qiagen N.V., for QIACUITY equipment and maintenance services. This contract does not have a set-aside designation. Qiagen has a history of providing products and services, such as DNA/RNA extraction kits, next-generation sequencing, and bioinformatics software, to support federal agencies'...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $55,000.00 firm fixed price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. This contract has a completion date of May 21, 2024. Qiagen is a foreign-owned, for-profit manufacturer that has provided a range of products and services to support federal...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $79,796.08 firm-fixed-price purchase order to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract is for the purchase of a QIAGEN EZ2 Connect MDX system. This equipment will support the CDC's biomedical research, public health, and healthcare programs. Qiagen has provided a range of laboratory products and services to various federal agencies in the past, including the Department of Health...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $82,823.10 firm fixed price purchase order to Qiagen, LLC, a division of Qiagen N.V., for the EZ2 CONNECT MDX SYSTEM FUL-3. This system supports the CDC's biomedical research, public health, and healthcare programs. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academia. The contract has no set-aside designation and is scheduled for completion by...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $148,000.00 contract is for the delivery of products and services to support the CDC's biomedical research, public health, and healthcare programs. This includes DNA/RNA extraction kits, next-generation sequencing, digital PCR systems, sample preparation equipment, bioinformatics...
This is a $14,288 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a division of Qiagen N.V. The contract has a period of performance from April 1, 2025 to March 31, 2026 for Qiagen to provide laboratory services under the IP0023 Statement of Work. No set-aside designation was used. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, and other applications. The company...
This is a $145,237 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract is for "other functions" and does not have a set-aside designation. Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academic research. Under this award, Qiagen is likely providing products and services to support the...
This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The $64,817.75 contract provides planned maintenance services for QIAGEN equipment, with a period of performance through March 31, 2024. Qiagen is a major supplier of molecular diagnostics products and services to federal agencies, including the Department of Health and Human Services, Department of Veterans...